Dr. Lindsay M. Bicknell, MD

Dr. Bicknell practices at Baylor Scott & White Continuing Care Hospital - Temple in Temple, Texas.

Dr. Bicknell's NPI, 1902249840, was assigned on April 10, 2013. Dr. Bicknell graduated from McGovern Medical School in 2013. Dr. Bicknell holds Texas license 574722.

Dr. Bicknell's primary practice is Baylor Scott & White Continuing Care Hospital - Temple, at 2401 South 31st St, Temple, TX 76504 in Bell County. The practice phone is (254) 771-8200.

Dr. Bicknell's primary practice is Baylor Scott & White Continuing Care Hospital - Temple in Temple, Texas. Dr. Bicknell is also affiliated with Baylor Scott & White Medical Center - Temple. The medical group on file is Baylor Scott & White Temple Roney Bone and Joint Institute, Temple.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bicknell practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Bicknell's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Bicknell is board certified in dermatology by the American Board of Dermatology. Dr. Bicknell is licensed in Texas.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, hives, itchy rashes and joint cyst among the conditions Dr. Bicknell treats.

CMS data shows 1,428 Medicare services from Dr. Bicknell across 12 procedure codes in 2024, for 409 Medicare patients. Medicare paid $51,809 for them.

CMS counts 409 Medicare patients who saw Dr. Bicknell in 2024. The largest group is 65 to 74, with 202 patients. 75% of them have high cholesterol, and 71% have high blood pressure. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bicknell's median patient age at 73, with 53% women.

In 2024, Dr. Bicknell wrote 831 Medicare Part D claims for 282 patients. 93% of them were for generic drugs. CMS names the drug for 674 of them, across 18 drugs with 11 or more claims each, at $17,663 in total drug cost. In 2023, CMS named 521 claims across 19 drugs.

Dr. Bicknell accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 446 procedures of removal of skin lesions by Dr. Bicknell, more than 85% of the clinicians it reports for that procedure.

Dmand AI links 16 papers to Dr. Bicknell, published from 2014 to 2024. 2023 was the busiest year, with 3. The most frequent topics are Antidepressive Agents, Tricyclic, Diagnosis, Differential and Exanthema. Dr. Bicknell has published most often in Cureus. Dr. Bicknell's most frequent co-authors are Neha Arora, DO, Nicole Niehues Dacy, MD and Chad D. Housewright, MD.

CMS Open Payments shows 10 general payments to Dr. Bicknell from 6 drug and device companies from 2017 to 2023. Food and beverage make up the largest share, 69% of the total. Janssen Pharmaceuticals, Inc paid the most, $70.

Dr. Bicknell graduated from McGovern Medical School in 2013. Dr. Bicknell is a member of AAD, ASDS, Texas Dermatological Society and Womens Dermatological Society.

Dr. Bicknell is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.